Tissue expression
Cell line expression
Protein structure

HS3ST3B1

Heparan sulfate-glucosamine 3-sulfotransferase 3B1
30ST3B1, 3OST3B1 
The protein encoded by this gene is a type II integral membrane protein that belongs to the 3-O-sulfotransferases family. These proteins catalyze the addition of sulfate groups at the 3-OH position of glucosamine in heparan sulfate. The substrate specificity of individual members of the family is based on prior modification of the heparan sulfate chain, thus allowing different members of the family to generate binding sites for different proteins on the same heparan sulfate chain. Following treatment with a histone deacetylase inhibitor, expression of this gene is activated in a pancreatic cell line. The increased expression results in promotion of the epithelial-mesenchymal transition. In addition, the modification catalyzed by this protein allows herpes simplex virus membrane fusion and penetration. A very closely related homolog with an almost identical sulfotransferase domain maps less than 1 Mb away. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
More gene data

All Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antigen sequence

Epitope

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
50 antibodies from 17 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Biorbyt
15 antibodies
Novus Biologicals
3 antibodies
R&D Systems
1 antibody
antibodies-online
8 antibodies
Invitrogen Antibodies
4 antibodies
Atlas Antibodies
1 antibody
Aviva Systems Biology
1 antibody
GeneTex
1 antibody
OriGene
1 antibody
LSBio
4 antibodies
NovoPro Bioscience Inc.
1 antibody
Creative Diagnostics
1 antibody
Abgent
1 antibody
Leading Biology
1 antibody
MyBioSource
1 antibody
Cusabio Biotech Co., Ltd
4 antibodies
MilliporeSigma / Merck KGaA
2 antibodies